Already back in 1999, Kaltschmidt et al. (1999) described the decreased immunoreactivity of NF-κB around various plaque stages of AD patients, and NF-κB activity protects neurons against oxidative stress (Heck et al., 1999). This evidence concerns the gene NFKB1 and Alzheimer disease.